L7 Informatics Automates Lab Operations and Supports Washington University School of Medicine with Workflow for Its Saliva-based COVID-19 Test

AUSTIN, Texas, Nov. 9, 2020 /PRNewswire/ — L7 Informatics announced that it has deployed L7|ESP to automate all lab operations starting with COVID-related workflow at the Genome Technology Access Center ([email protected]) in the McDonnell Genome Institute at the Washington University School of Medicine. The COVID-related workflow supports the new saliva test, developed by Washington University researchers, that is used to detect the SARS-CoV-2 virus.

L7 Informatics, provides software and services that enable synchronized solutions for scientific research and development. L7’s Enterprise Science Platform (ESP) is a scientific information management (SIM) solution that enables crop science companies to connect wet lab, greenhouses, sequencing and analytical processes with instruments and software systems to accelerate research and drive organizational efficiency. (PRNewsfoto/L7 Informatics, Inc.)

L7|ESP is CLIA (Clinical Laboratory Improvement Amendments) compliant and enables diagnostic organizations to use a single platform for registering and processing samples, running complex analyses, generating reports, and provides complete end-to-end assay automation. L7|ESP is designed to increase reproducibility and efficiency while decreasing errors and turnaround time.

According to L7 Informatics President and CEO, Vasu Rangadass, Ph.D., “L7|ESP will enable the COVID-related workflow at Washington University’s McDonnell Genome Institute (MGI) to scale to 10,000 samples per week if need be, and this ability to scale-up could help support the number of tests that can be conducted.”

L7 carried out the content implementation at GTAC in four releases. The main tasks performed as part of this project include Sample Accessioning, Saliva Processing, RT/STA, Prepare and Load IFC Plate, Analysis/ Reporting, Inventory App, Protocols/workflows/workflow chain configs, and Locations App.

Richard Head, a professor of genetics and director of the Genome Technology Access Center at the McDonnell Genome Institute, added, “This is a COVID-19 test process that can be used at scale, and it is essential that test results are reproducible and samples can be processed efficiently. We have used L7’s ESP technology to help us reach that goal.” 

About L7 Informatics
The L7 mission is to revolutionize the scientific process by streamlining process and data management and thereby accelerate precision health across life sciences, healthcare, and food value-chains. L7 Informatics provides software and services that enable synchronized solutions for scientific research and development. For more information, visit

Media Contact
Jessica Tobey
L7 Informatics, Inc.
[email protected]


Cision View original content to download multimedia:

SOURCE L7 Informatics, Inc.

Source Article

Read More

Kiana Analytics Automates Compliance With California AB-685 New Reporting Obligations for COVID-19 Workplace Exposure

New law requires employers to provide written notice of COVID-19 exposure and empowers CAL/OSHA to immediately shut down non-compliant facilities

Kiana Analytics, Inc., the premier location-based platform company delivering accurate proximity solutions to organizations worldwide, announces today that its Digital Contract Tracing Solution is helping California businesses (Public and Private) meet painstaking and timely AB-685 requirements.

California’s AB-685 will go into effect January 1, 2021 through January 1, 2023. It requires businesses to:

  • Identify all potentially exposed individuals present at a worksite upon identification of a positive COVID-19 case;

  • Provide written notice within 1 business day to all personnel who were exposed.

Penalties for non-compliance include CAL/OSHA’s authority to issue immediate “stop work orders” and fines of $25,000 per violation.

Kiana’s Digital Contact Tracing is part of its Smart Facility Management Platform helping employers immediately comply with AB-685 and effectively execute a Return to Work pandemic plan. Features include:

  • Simplified, scalable management. Receive exposure tracing in real-time and automate compliance of exposure notification and documentation requirements to Union and State Health Departments.

  • Seamless contact tracing that integrates with your existing WiFi infrastructure. No app or additional hardware required.

  • Privacy Preservation. All private data stays behind your firewall.

  • Improved governance and reduced business risk. Immediately identify potentially exposed people (per CDC guidelines), automate identification of density violations, and inform staff when surgical cleaning is needed.

  • Reduced cost of ownership and future proof. Re-engineer your site to adapt to new requirements for space utilization, physical security, and employee wellness post-pandemic.

“California is making progress in reducing the number of COVID-19 cases,” said Nader Fathi, CEO of Kiana Analytics. “AB-685 will allow workers and local public health officials to keep employees and the public safe. We at Kiana are delighted to help facilitate this reporting process and keep California employees and the public safe and enable return to work.”

For additional information about Kiana’s AB-685 solution, click here.

About Kiana

Founded in 2013, Kiana Analytics is a fast-growing, California Consumer Privacy Act (CCPA) compliant company with offices in Silicon Valley. For more information, visit

View source version on


Lana Sansur
RMR & Associates
(301) 230-0045 x 440
[email protected]

Nader Fathi, CEO
Kiana Analytics
(800) 761-4522
[email protected]

Source Article

Read More